CALM Pregnancy: results of a pilot study of mindfulness-based cognitive therapy for perinatal anxiety

Goodman, Janice H.; Guarino, A. J.; Chenausky, Kerry L.; Klein, Lauri; Prager, Joanna; Petersen, Rebecca P.; Forget, Avery; Freeman, Marlene P.

doi:10.1007/s00737-013-0402-7

Cited by 158 publications

(142 citation statements)

References 95 publications

(107 reference statements)

Supporting

Mentioning

132

Contrasting

Unclassified

Order By: Relevance

“…This finding is in collaboration with many other studies reporting antenatal anxiety ranges between 12.2% to 39%. 15,16 The findings of significantly higher antenatal anxiety during third trimester is in agreement with previous reports by Madhavanprabhakaran et al where they found higher third trimester pregnancy-specific anxiety in a large sample of 500 pregnant females. That study used State Trait Anxiety Inventory and Pregnancy-Specific Anxiety Inventory and they also identified young age, nulliparous status and nuclear family as common risk factors of pregnancy-specific anxiety.…”

Section: Discussionsupporting

confidence: 92%

A study of antenatal anxiety: comparison across trimesters

Priyambada

Pattojoshi

Bakhla

2017

Int J Reprod Contracept Obstet Gynecol

View full text Add to dashboard Cite

Background: The aim of present study was to investigate the antenatal anxiety across all three trimesters of pregnancy.Methods: This is a cross sectional, observational study for which data is collected from consenting subjects attending antenatal Out Patients department for routine antenatal checkup. Data included socio demographic information’s and Hospital Anxiety and Depression Scale and statistical analysis done.Results: Out of 169 Pregnant females 27.8% were during first trimester, 40.8% during second trimester and 31.4% during 3rd trimester. The mean anxiety scores for first, second and third trimester was 10.74±2.97, 11.69±3.09 and 14.20±3.10 respectively. Independent t test revealed significantly higher anxiety scores for third trimester when compared to first trimester scores (t= -6.035, p value = 0.000).Conclusions: This study finds a significantly higher antenatal anxiety during third trimester of pregnancy.

show abstract

Section: Discussionsupporting

confidence: 92%

A study of antenatal anxiety: comparison across trimesters

Priyambada

Pattojoshi

Bakhla

2017

Int J Reprod Contracept Obstet Gynecol

View full text Add to dashboard Cite

show abstract

“…[101][102][103] An evaluation of group mindfulness-based cognitive therapy for perinatal anxiety showed statistically and clinically significant improvements in anxiety, worry, and depression, as well as a significant increase in selfcompassion and mindfulness. 104 Additionally, in this study 94% of women with GAD no longer met diagnostic criteria posttreatment.…”

Section: Mindfulness Trainingmentioning

confidence: 60%

Perinatal Generalized Anxiety Disorder: Assessment and Treatment

Misri

Abizadeh

Sanders

et al. 2015

Journal of Women's Health

113

View full text Add to dashboard Cite

Perinatal generalized anxiety disorder (GAD) has a high prevalence of 8.5%-10.5% during pregnancy and 4.4%-10.8% postpartum. Despite its attendant dysfunction in the patient, this potentially debilitating mental health condition is often underdiagnosed. This overview will provide guidance for clinicians in making timely diagnosis and managing symptoms appropriately. A significant barrier to the diagnosis of GAD in the perinatal population is difficulty in distinguishing normal versus pathological worry. Because a perinatal-specific screening tool for GAD is nonexistent, early identification, diagnosis and treatment is often compromised. The resultant maternal dysfunction can potentially impact mother-infant bonding and influence neurodevelopmental outcomes in the children. Comorbid occurrence of GAD and major depressive disorder changes the illness course and its treatment outcome. Psychoeducation is a key component in overcoming denial/stigma and facilitating successful intervention. Treatment strategies are contingent upon illness severity. Cognitive behavior therapy (CBT), relaxation, and mindfulness therapy are indicated for mild GAD. Moderate/severe illness requires pharmacotherapy and CBT, individually or in combination. No psychotropic medications are approved by the FDA or Health Canada in pregnancy or the postpartum; off-label pharmacological treatment is instituted only if the benefit of therapy outweighs its risk. SSRIs/SNRIs are the first-line treatment for anxiety disorders due to data supporting their efficacy and overall favorable side effect profile. Benzodiazepines are an option for short-term treatment. While research on atypical antipsychotics is evolving, some can be considered for severe manifestations where the response to antidepressants or benzodiazepines has been insufficient. A case example will illustrate the onset, clinical course, and treatment strategies of GAD through pregnancy and the postpartum.

show abstract

“…Thus it has been argued that weight loss interventions or interventions to prevent excessive gestational weight gain, could benefit from a multidisciplinary approach including a healthy lifestyle and counseling as well as an antenatal screening for psychological health. Strikingly, none of the included intervention studies (Bogaerts et al, 2013b;Claesson et al, 2014Claesson et al, , 2010 included anxiety-specific screenings or treatment modules although symptom-specific evidence-based intervention programs are available and results for cognitive behavioral programs during pregnancy are promising (Goodman et al, 2014b).…”

Section: Discussionmentioning

confidence: 99%